Several studies reported the overexpression of FOXM1 stimulates the proliferation of tumor cells during the progression of NSCLC and other types of cancers and also associated with poor overall survival (13–15, 65). The gene discussed is FOXM1; the disease is non-small cell lung carcinoma.